Virus integration into the host genome is a characteristic step during cervical carcinogenesis. Experimental data provide evidence that integration could result in increased levels of oncogene (E6/E7) transcripts. This is the first study in which the level of viral transcripts is correlated to the physical state of the viral genome in cervical intraepithelial neoplasia (CIN) and cervical carcinomas (CxCa). Using the APOT-assay integrate-derived transcripts only were detected in 3/28 (11%) CIN and in 28/55 (51%) carcinomas, respectively. The remaining biopsies contained either episome-derived transcripts only or both mRNA species. SybrGreen real time reverse transcriptase-PCR assays were used to quantify viral gene expression for (i) all transcripts initiated from p97, (ii) full-length E6, (iii) E6*I and (iv) E5 transcripts. E6/E7 transcript levels showed a broad distribution but similar median values irrespective of histopathological grading and physical state of the viral genome. Biopsies with integrate-derived transcripts only generally lacked E5-specific mRNA. Our data do not support the hypothesis that HPV integration invariably results in high levels of oncogene transcripts. Instead, constitutive expression of oncogene transcripts rather than the level of expression appears to be decisive for transformation and the maintenance of the malignant phenotype.
Introduction
Persisting infection with high-risk human papillomaviruses (HR-HPV) represents the most significant risk factor for cervical cancer (Munoz and Bosch, 1992; IARC, 1995) . The majority of HPV-induced cancers are squamous cell carcinomas (SCCs) which arise in a multistep fashion from precursor cervical intraepithelial lesions (CIN) (Ostor, 1993; Arends et al., 1998) . The life cycle of HPV is unique in that the virus infects replicative competent cells of the basal and parabasal layer but requires terminally differentiating cells for its replication. To allow for replication in post-mitotic cells the host DNA replication machinery needs to be reprogrammed by the virus . This is achieved by targeting negative growth regulatory proteins. The HR-HPV E7 oncoproteins bind and degrade the retinoblastoma tumor suppressor protein (pRB) thereby releasing the transcription factor E2F which in turn induces the S-phase genes cyclin A and cyclin E (Munger et al., 2001) . In concert, E7 also inactivates the cyclin inhibitors p21
Cip1 and p27
Kip1
(Zerfass- Thome et al., 1996; Funk et al., 1997) . However, free E2F also activates p14 ARF which stabilizes p53 (Itoshima et al., 2000) . This results in an antiproliferative response either by cell-cycle arrest or apoptosis. To circumvent this, the HR-HPV E6 oncoprotein induces rapid proteasomal degradation of p53 (Scheffner et al., 1990) . This complex interaction ensures virus DNA replication in differentiating cells. However, in proliferating cells of the basal and parabasal layer the very same viral gene activity induces genetic instability. This is evident during the process of HPV-induced immortalization in cultured cells (Durst et al., 1987 (Durst et al., , 1995 . These cells frequently acquire numerical chromosomal imbalances and structural chromosomal changes such as translocations, deletions and amplification at early passages (Solinas-Toldo et al., 1997) . Moreover, it was shown that HR-HPV E6 and E7 oncoproteins cooperate to induce centrosome-related mitotic aberrations and aneuploidy (Duensing et al., 2000) . In particular, HR-HPV E7 rapidly induces abnormal centrosome duplication, which leads to aberrant mitotic spindle pole formation and as a consequence chromosome missegregation. These mitotic disturbances are potentiated by HR-HPV E6. In situ hybridization analyses of precancers reveal at most only low levels of viral E6-E7 transcripts in basal and parabasal cells of low-grade lesions (CIN1) in comparison to high-grade lesions (CIN2/3) (Durst et al., 1992) . This suggests that viral oncogene expression is suppressed. There is also ample experimental data in support of this (zur Hausen, 2002) . On the basis of the above data one of the key steps in the current model for cervical carcinogenesis is the deregulated expression of the viral oncogenes in proliferative competent cells. Integration of the viral DNA into the host genome is frequently observed in invasive cervical carcinomas and in a subset of CIN3 and is thought to be one of the driving factors for progression . In particular the fact, that integration frequently disrupts the viral regulatory gene E2 from its own promoter is taken as an argument for a constitutive strong expression of the viral oncogenes (Baker et al., 1987; Romanczuk and Howley, 1992) . Moreover, experimental data suggest that cis-acting elements within the flanking cellular sequences can positively modulate viral gene expression (von Knebel Doeberitz et al., 1991) . There is also some evidence that integratederived viral-cellular fusion transcripts exhibit higher RNA stability because of the loss of AU-rich elements (AREs) present in viral 3 0 -UTR (untranslated region) sequences . Taken together one would expect higher steady-state levels of viral oncogene transcripts in precancers and invasive carcinomas as a consequence of virus integration. To address this question, we have determined the relative level of viral oncogene transcripts by quantitative realtime PCR and compared this to physical state of the viral genome.
Results

Performance of qRT-PCR assays
Quantitative PCR is an established and reliable method permitting the sensitive and specific detection and quantification of DNA or RNA species. We have established SybrGreen assays for different HPV16 transcript types ( Figure 1a and Table 1 ). Whereas the assay E6all detects all transcripts expressed from p97 assays E6FL and E6*I detect only full-length or spliced E6*I message, respectively. Furthermore, we used the HPV16 E5 assay to quantify E5 coding transcripts. All HPV16 assays showed the same PCR efficiency (>98%) and dynamic range (Figure 1b) .
HPV physical state in CIN and CxCa
Integration of the viral genome invariably uncouples the non-coding region of the virus together with the oncogenes E6 and E7 from the downstream located genes. The breakpoint is frequently within the E1-E2 region of the viral genome. Transcription from the viral promoter p97 results in characteristic viral-cellular fusion transcripts. These can easily be detected by the APOT assay. Using this approach, we determined the physical state of the viral DNA in 28 CIN and 55 CxCa samples (Table 2 ). Whereas the majority of CIN samples showed episome-derived transcripts only, integratederived transcripts were detected in 51% of carcinoma 6 to 10 copies were amplified with all assays and analyses revealed an identical dynamic range and equal PCR efficiencies greater than 98% (as calculated from the slope of the regression curve).
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HPV16 gene expression and physical state
The central aim of this study was to correlate the level of HPV oncogene expression with the physical state of the viral genome. Figure 2 shows the expression levels of transcripts initiated from p97 (E6all) and the expression levels of E5 coding transcripts depending on the HPV state but independent of the histological grading of the lesion. The steady decline of E5 expression in samples with viral episomes only compared to samples with both episomal and integrated forms and samples with integrated DNA only is in line with the expected findings and confirms the reliability of the APOT assay. Although most of the samples with integrated HPV genomes show low or absent expression of E5, we also determined higher levels of E5 in a few CxCa samples. Contrary to the clear correlation between E5 expression and HPV status, we observed a similar expression level for E6/E7 transcripts in all groups ( Figure 2 ). Median expression levels of E6/E7 in samples with episomes, mixed or integrated DNA (32 878, 14 263 and 23 292 copies in 10 ng RNA, respectively) were not significantly different (Mann-Whitney test for pairwise comparisons, P>0.05).
To avoid an intrinsic bias caused by different proportion of CIN and CxCa in the HPV status groups, we analysed HPV16 E6/E7 expression in relation to both histopathological findings and the genome state ( Figure 3 ). Furthermore, we also determined the expression levels of HPV16 E6*I which represents the most abundant transcript in all lesions. Since the PCR primers for the latter assay bind to different exons, we can also rule out the co-amplification of residual DNA. Both PCR assays (E6all and E6*I) revealed comparable results with respect to the expression levels in the different groups. E6/E7 expression is highly variable within all sample groups, but there are no statistical significant differences between the groups. CIN biopsies with both episomal and integrated viral DNA show exceptional low levels of HPV transcripts but this result is obviously limited because of the low number of cases (n ¼ 2).
To analyse viral oncogene expression in more detail, we calculated the ratio of all transcripts initiated at p97 (E6all) to full-length E6 message (E6FL) on single sample basis (Figure 4) . The E6 oncoprotein can only be encoded by full-length E6 mRNA (E6FL) whereas the spliced transcripts (E6*I) code primarily for the E7 protein (Sedman et al., 1991) . The ratio E6all to E6FL therefore provides an indication of the level of E6 encoding mRNA relative to total transcripts initiated at p97. A subset of CxCa samples showed high ratios reflecting low levels of E6 full-length message. Moreover, the median ratio was significantly higher in CxCa samples than in CIN samples (Mann-Whitney test, Po0.001).
Tracing residual DNA For the detection of spliced transcripts (E6*I), we used exon-spanning primers thereby avoiding amplification of residual DNA. This however, was not possible for the assays E6all, E6FL and E5. To determine the amount of residual DNA in the samples, we performed RT-minus controls (n ¼ 30). The median level of DNA contamination corresponded to approximately 1% of the level of full-length E6 transcripts in all sample groups irrespective of the physical state of the viral genome (data not shown). Furthermore, we verified a possible bias to E6all/E6FL ratios by residual DNA (Figure 5 ). MannWhitney analyses revealed no significant differences between samples with low E6all/E6FL ratio (o10, n ¼ 19) or high ratios (>10, n ¼ 11) with respect to the amount of residual DNA. This clearly indicates that low E6all/E6FL ratios are not the result of higher amounts of residual DNA.
Discussion
One factor considered to be of key importance for the progression of CIN to invasive cervical cancer is integration of HPV into the host genome . Hopman et al. (2005) have shown by in situ hybridization that 88% of CIN2/3 associated with microinvasive carcinoma contained integrated viral DNA. In contrast, the characteristic punctuate signal Figure 3 Relative copy numbers of E6all transcripts (white boxes) and spliced E6*I transcripts (hatched boxes) in CIN and CxCa samples in relation to the physical state of the HPV genome (e, episomes; i, integrates; e þ i, episomes þ integrates). Figure 4 Determination of the fraction of E6 full-length transcripts (E6FL) among all transcripts initiated from p97 in CIN and CxCa samples (E6all:E6FL ratio). CxCa samples with high ratios reflecting lower levels of E6 full-length message are equally distributed in groups with different physical state of the viral genome (e, episomes; i, integrates; e þ i, episomes þ integrates).
Figure 5
Percentage of residual DNA in samples with high (>10) or low (o10) E6all/E6FL ratio. Mann-Whitney analyses revealed no statistically significant differences between both groups. HPV16 integration and E6/E7 oncogene expression N Häfner et al of integrated viral DNA was only observed in 29% of solitary CIN2/3. High integration frequencies have also been observed in several other studies in which other techniques for the detection of integrated viral DNA (DIPS, E6/E2 ratios) or integrate-derived viral transcripts (APOT) were used (Klaes et al., 1999; Luft et al., 2001; Peitsaro et al., 2002; De Marco et al., 2007) . It is still a matter of debate whether HPV DNA integration precedes E6/E7 induced genetic instability or rather is a consequence thereof. In an in vitro study acquisition of high levels of genomic instability in cervical keratinocytes in monolayer culture occurred after integration of HPV16 (Pett et al., 2004) . On the other hand, Melsheimer et al. (2004) have shown that in CIN and cervical carcinomas aneuploidization precedes integration of HPV DNA in the progression of cervical dysplasia. However, irrespective of a temporal association between integration and genetic instability, the current concept of cervical carcinogenesis suggests that integration provides the cell with a selective growth advantage (Duensing and Munger, 2004; Wentzensen et al., 2004) . Several in vitro studies indicate that this growth advantage results from an enhanced expression of HPV E6 and E7. HPV integration in W12 cells was associated with an increase in levels of detectable E7 protein. Maximal E7 levels correlated with the acquisition of structural chromosomal abnormalities (Alazawi et al., 2002; Pett et al., 2004) . High oncogene levels are attributed to the functional loss of the viral E2 gene product which acts as an intrinsic repressor of E6/E7 expression (Romanczuk and Howley, 1992) . Moreover, viral-cellular fusion transcripts are devoid of the instability elements located in the 3 0 -region of the viral mRNA and may thus have a longer half-life . However, to date, high levels of E6/E7 gene expression have never been correlated to viral integration in biopsy material. Our analyses of 83 CIN and cervical carcinomas revealed the presence of episomes, integrates and both species in 46.9, 37.4 and 15.7% respectively. The observed frequencies of episome-and integrate-derived transcripts in CIN versus cervical carcinomas (Table 2) are also in line with the published data obtained with the APOT technique (Klaes et al., 1999) . To quantify HPV transcript levels, we used the same RNA preparations as for the APOT assay. The absence or very low levels of E5 coding transcripts in samples with integrated viral genomes only (Figure 2 ) confirm our classification of the physical state of the viral genome based on the APOT results. Disruption of the viral genome frequently occurs in the E1 or E2 coding sequences and thereby uncouples the promoter p97 from the E5 open reading frame, thus causing loss of E5 expression. However, low levels of E5 transcripts could be derived from adjacent cells still harbouring episomes or from full-length or multiple HPV genomes integrated at one or several chromosomal sites. In tumours with multiple integration sites, viral gene expression at several sites was shown to be repressed by methylation in favour of a dominant papillomavirus transcription domain (Van Tine et al., 2004) . However, the assays used were not sensitive enough to exclude low levels of expression. Despite a clear correlation between the lack of E5 transcripts and integration, we detected no differences in the levels of E6/E7 expression in relation to the physical state of the viral genome (Figure 2 ). This result is consistent even after histopathological stratification of the biopsy material (Figure 3) : Neither e-CIN nor e-CxCa (34 470 and 31 900 median copies in 10 ng RNA, respectively) expressed lower levels of oncogene transcripts than i-CxCa (median copy number of 22 805). These data strongly suggest that HPV integration per se does not invariably result in an increase in oncogene expression. Moreover, the highly variable expression levels of oncogene transcripts that we observed in carcinomas are in line with the results of Rosty et al. (2005) . Variable oncogene expression was also detected in CIN samples (Figure 3) . Furthermore, we could detect expression of full-length E6 transcripts in all grades of disease even in CIN1, albeit the number of CIN1 examined was very small (n ¼ 7). Control reactions without reverse transcriptase revealed low amounts of residual undigested DNA averaging to less than 1% of full-length E6 transcripts in all groups. Thus the predominant amount of full-length E6 copies is not due to a contamination with residual DNA. These results are in agreement with results obtained by consensus reverse transcriptase-PCR showing E6 fulllength transcripts of different HPV types in all of 31 CIN samples (Nakagawa et al., 2000) . Interestingly, we observed higher ratios of overall transcripts initiated from p97 to full-length E6 transcripts (E6all:E6FL) in CxCa in comparison to CIN (Figure 4 ). Since only E6FL transcripts encode the oncoprotein E6 it may be speculated that the level of E6 oncoprotein could be higher in CIN than in CxCa. Moreover, CxCa samples with high E6all:E6FL ratios were equally distributed in the groups with episomal or integrated genomes suggesting that integration as such has no effect on splicing.
The high levels of E6/E7 expression in CIN which we observed appear to be contradictory to the data obtained in several other studies (Falcinelli et al., 1993; Riethdorf et al., 2001; Sotlar et al., 2004; Molden et al., 2005; Andersson et al., 2006) . The most probable explanation for this is the sampling strategy used (biopsies versus cervical scrapes). Although analyses of exfoliated cells enable an easy access to clinical material and are clearly ideal in a diagnostic setting the results are not representative for the overall quantity of the RNA or for the diversity of viral mRNA species in the underlying lesions (Middleton et al., 2003) . Moreover, in our study we did not relate E6/E7 expression levels to viral genome copy number. A direct comparison of DNA and RNA would not be informative since it is known that viral gene expression from individual sites can be selectively suppressed (Van Tine et al., 2004) .
In conclusion, we observed highly variable levels of viral oncogene expression in CIN and CxCa, which were independent of histological grading and the physical state of the viral genome. These data support the hypothesis that HPV integration primarily ensures HPV16 integration and E6/E7 oncogene expression N Häfner et al constitutive expression of the viral oncogenes. The minimal levels of viral oncogene expression required to initiate carcinogenesis and to sustain the transformed phenotype of the cell probably cannot be determined experimentally. Moreover, other consequences of integration such as insertional mutagenesis and/or effects on the transcriptome should also be considered and should be analysed systematically.
Materials and methods
Surgical samples
All biopsies were taken for diagnostic purposes (CIN samples) or for curative surgery (CxCa samples). Written informed consent was obtained from all patients. Biopsies were immediately snap-frozen in liquid nitrogen, stored at À80 1C and HPV typed using the GP5 þ /6 þ PCR system (Jacobs et al., 1997 
RNA extraction and reverse transcription
Total RNA was extracted from 20 sections of 20 mm thickness using the RNA Blood Mini Kit (Qiagen, Hilden, Germany) according to the manufacturer's instructions, which include DNase treatment. RNA concentration and quality were determined by spectrophotometry (NanoDrop ND-1000). A measure of 200 ng RNA were reverse transcribed in 40 ml using oligo-dT primer (500 nM), dNTP (500 nM each), DTT (10 mM), first-strand buffer, RNaseOUT (20 U) and SuperScriptII reverse transcriptase (200 U) (Invitrogen, Karlsruhe, Germany). For minus-RT controls the reverse transcriptase was replaced by Aqua Bidest to keep the reaction volume constant.
Real-time PCR
All real-time PCR experiments were run on an ABI 7300 SDS system (Applied Biosystems, Darmstadt, Germany). Reactions were performed in 25 ml volume using the PowerSybrGreen Master Mix (Applied Biosystems) containing forward and reverse primers (500 nM each) and cDNA equivalent to 10 ng RNA. Primer-specific data are listed in Table 1 . The PCR steps were as follows: initial denaturation and hot-start activation at 95 1C for 10 min followed by 40 cycles of denaturation phase at 95 1C for 15 s, primer-specific annealing for 20 s at different temperatures (see Table 1 ) and elongation at 72 1C for 40 s. Subsequently, the melting temperature of the PCR product was determined to ensure specificity. All real-time PCR results were quantified using the relative standard curve approach (Giulietti et al., 2001) . We used serial dilutions from 10 6 to 10 copies of plasmid cloned target sequences (pCRII-TOPO, Invitrogen) as standard curves. Of each cDNA, we determined housekeeping gene (HKG) and target gene expression in duplicate. Target gene expression was normalized to the geometric mean of the expression of the two most stable HKGs in the tissues analysed (Vandesompele et al., 2002) . These were shown to be b-actin and glyceraldehyde-3-phosphate dehydrogenase (GAPDH). In addition to determining the normalization factor (NF) for HKGs, we assessed the proportion of dysplastic cells in haematoxylin-eosin-stained tissue by morphological criteria only. Immunohistochemical staining for p16 and Ki-67 were used to aid histopathological assessment of the lesions. However, these markers are not ideal to define the boarders of the lesions in particular that of lowgrade lesions. Samples were judged to contain o10, 25, 50, 75 or >90% dysplastic cells which contributed to normalization by factor 10, 4, 2, 1.5 or 1, respectively (normalization factor dysplastic cell fraction NF(DCF)). Furthermore, we included a normalization factor for cDNA quality as measured by GAPDH 5 0 -3 0 ratio (5 0 -3 0 ratio ¼ 5 0 -GAPDH copy number/ 3 0 -GAPDH copy number). Copy numbers of GAPDH cDNA ends were determined by 5 0 -and 3 0 -qPCR assays exhibiting the same PCR efficiency. This ratio was used to calculate copy numbers of 5 0 -located PCR amplicons (HPV16 E6all, E6FL and E6*I) to avoid a bias by RNA degradation or incomplete cDNA synthesis. Altogether relative copy numbers were calculated from raw data (plasmid copy equivalents, PCE) using the following equation: relative copy number ¼ [(PCE*NF(DCF))/((NF(HKG)*5 0 -3 0 ratio))]. For calculation of HPV16 E5 expression the same equation but without 5 0 -3 0 ratio was used.
APOT assay
We used the APOT assay (amplification of papillomavirus oncogene transcripts) to determine the physical state of HPV16 as described previously (Klaes et al., 1999) . This 3 0 -RACE protocol is based on reverse transcription using a modified oligo-dT primer followed by nested PCR with 5 0 -primers located in the E7 open reading frame and a 3 0 -Frohman primer. PCR products were separated in 1.2% agarose gels, blotted onto nylon membranes and hybridized with E7 and E4 specific probes. Hybridization signals for both E7 and E4 and a fragment length of 1 kb were scored as episome-derived transcripts whereas hybridization signals for E7 only and offsize fragment length were indicative of transcripts derived from integrated viral DNA.
